Emerson Electric (EMR)
NYSEIndustrialsSpecialty Industrial MachinerySnapshot 2026-07-07
Reading EMR? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track EMR free→NYSEIndustrialsSpecialty Industrial MachinerySnapshot 2026-07-07
Reading EMR? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track EMR free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder with a focus on steady cash flow and shareholder returns. The current thesis state is intact, supported by strong recent financial performance, though management priorities show mixed results.
The market appears to be pricing in a neutral valuation compared to peers, with an expectations gap indicating that investors are not overly optimistic or pessimistic. The recent rise in valuation suggests that the market recognizes the company's potential, but it remains cautious.
Fundamentals are likely to reflect mixed execution from management, particularly in achieving free cash flow and EPS targets. The near-term risk is moderate, with a low probability of missing estimates, but the company's history and industry trends warrant close observation.
The long-term thesis hinges on sector performance, particularly the results of key industry peers like GEV, ETN, and PH. Positive earnings and guidance from these companies could support EMR, while negative trends could pose risks to its momentum.
Over the next 1 to 3 years, EMR's performance will depend on its ability to navigate sector dynamics and meet management targets. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-07-07
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Weak sales growth could signal ongoing challenges in the industrial sector. This impacts investor confidence.
Confirms:Q3 net sales growth guidance of 4.5% or lower.
Disproves:Q3 net sales growth guidance above 4.5%.
Why it matters: Meeting EPS guidance would show Emerson is on track for its financial goals. Consistent performance is key for investor confidence.
Confirms:Q3 EPS lands between $4.79 and $4.89.
Disproves:Q3 EPS falls below $4.79.
Why it matters: More orders mean strong demand. This can increase future revenue.
Confirms:Underlying orders growth exceeds 5% in Q2 2026.
Disproves:Underlying orders growth falls below 5% in Q2 2026.
Why it matters: Progress on buying back shares shows a commitment to shareholders. This can help raise the stock price.
Confirms:Management says they will complete $500M or more in share repurchases by Q3 2026.
Disproves:Management says share repurchases will be much less than $500M by Q3 2026.
Why it matters: Returning $2.2B to shareholders is crucial. Slow progress may worry investors.
Confirms:Progress report shows less than $1B returned to shareholders by mid-2026.
Disproves:Progress report shows over $1B returned to shareholders by mid-2026.
Why it matters: Hitting this target shows that Emerson can make cash. It also helps shareholders. This shows the company is doing well.
Confirms:Free cash flow reported at $3.5B or higher.
Disproves:Free cash flow reported below $3.5B.
Why it matters: Meeting this growth target would indicate effective sales strategies and strong market demand. It is vital for overall performance.
Confirms:Net sales growth reported at 5.5% or higher.
Disproves:Net sales growth reported below 5.5%.
Why it matters: If sector growth speeds up, it could benefit Emerson's sales. Slower growth may hurt.
Confirms one read:Sector revenue growth speeds up to over 10% each year.
Confirms the other:Sector revenue growth slows below 5% year over year.